Promoted on Potential...The Gender Gap No One Talks About
Why do young men get promoted on promise, while women have to prove themselves over and over?
In this episode, we unpack the data behind one of the workplace’s most persistent double standards, the “potential vs. performance” bias.
Drawing from McKinsey and LeanIn’s latest research, we explore how early-career promotions favor men, how bias shows up in performance reviews and leadership decisions, and why this gap hits women of color the hardest.
You’ll hear what companies can do to break the cycle, how individuals can advocate for themselves and others, and why rethinking how we define leadership potential might be the key to closing the gender gap once and for all.
4 Sept 2025
From Lab to Patient - Revolutionizing Cell Therapy Manufacturing
Cell therapy is one of the most promising frontiers in medicine — but scaling it remains a massive challenge. In this episode, we explore the complex landscape of cell therapy manufacturing, where automation is both a critical solution and a major stumbling block. From high capital costs and regulatory hurdles to the lack of interoperable systems and specialized talent, we break down why so few companies have cracked the code.
Then we look at how Cellistic is changing that. With its integrated Pulse™ and Echo™ platforms built on iPSC (Induced Pluripotent Stem Cell) technology, Cellistic is offering an end-to-end solution for "off-the-shelf" allogeneic therapies that’s faster, more reliable, and potentially game-changing. We discuss how automation not only cuts costs and reduces errors, but also supports scalability, quality control, and regulatory readiness — if done right.
Whether you’re navigating your own manufacturing strategy or just trying to understand the future of scalable cell therapy, this episode is for you.
🎙️ Topics Covered:
Why automation is so hard to implement in cell therapy
The gap between automation’s promise and actual adoption
How iPSCs unlock scalability for allogeneic therapies
What makes Cellistic’s Pulse™ and Echo™ platforms different
Real-world barriers (and enablers) of moving from benchtop to bedside
Tune in to understand what’s standing in the way of cell therapy’s growth — and what’s finally pushing it forward.
1 Sept 2025
Manufacturing drugs...... What? Like its hard?
Join me as I explore the unique and demanding challenges in pharmaceutical manufacturing, from stringent regulatory compliance and ensuring unwavering quality control to managing intricate global supply chains and integrating cutting-edge technologies.
Discover why producing life-saving drugs is anything but simple
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
1 ratings
Host of Kudla Cracks It?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
